Bone and Mineral Metabolism Disorders
Rockwell Medical Inc. reported that it has received FDA approval to begin manufacturing Calcitriol, the company’s active vitamin D injection for the management of hypocalcemia in patients undergoing chronic hemodialysis.
In a press release, Rockwell said FDA action on its prior approval supplement “was necessary in order to market and commercialize Calcitriol in the United States.”
This activity is supported by an educational grant from ViiV Healthcare.
No commercial support for this activity.
Transplant Centers Resource Center
Search Healio's robust listing of national and international medical meetings.
Tell us what you think about Healio.com »
Get the latest news and education delivered to your inbox
©2018 Healio All Rights Reserved.